Repaglinide induced Acute Hepatotoxicity

Authors

  • Suresh Jaiswal Department of Medicine, Mercy Catholic Medical Center, Drexel University College of Medicine, Philadelphia
  • R Mehta Department of Medicine, Mercy Catholic Medical Center, Drexel University College of Medicine, Philadelphia
  • M Musuku Department of Medicine, Mercy Catholic Medical Center, Drexel University College of Medicine, Philadelphia
  • L Tran Department of Medicine, Mercy Catholic Medical Center, Drexel University College of Medicine, Philadelphia
  • Jr W McNamee Department of Medicine, Mercy Catholic Medical Center, Drexel University College of Medicine, Philadelphia

DOI:

https://doi.org/10.31729/jnma.236

Abstract

Repaglinide is considered a safe drug; adverse events are mild to moderate which includes
hypoglycemia, headache, nausea, vomiting, diarrhea and dyspepsia as similar to sulphonylureas.
This case report describes a rare side effect of repaglinide. In rare cases, elevated liver enzymes have
been noted. We report a case of acute hepatotoxicity in a 78 year old woman who developed acute
hepatotoxicity while taking repaglinide.
Key Words: hepatotoxicity, hypoglycemia, repaglinide,

Downloads

Published

2009-04-01

How to Cite

Jaiswal, S., Mehta, R., Musuku, M., Tran, L., & McNamee, J. W. (2009). Repaglinide induced Acute Hepatotoxicity. Journal of Nepal Medical Association, 48(174), 162–4. https://doi.org/10.31729/jnma.236

Issue

Vol. 48 No. 174 (2009)

Section

Case Reports

License

JNMA allow to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNMA work is licensed under a Creative Commons Attribution 4.0 International License. More about Copyright Policy.